The recent findings of Botond Roska and his research group may introduce radically innovative methodologies for treating visual impairments: their approach involves the targeted delivery of healthy mitochondria into dysfunctional cells. Our team joined the press conference from the Frontiers office, which showcased the latest study published in Nature. The study was conducted by Botond Roska and 28 other international researchers.
MoreAs the first top-level researcher to join the Frontiers Fellow community, Botond Roska shared his perspectives on the new Hungarian knowledge center and his scientific achievements. The Wolf Prize-winning researcher believes that science is more than a job. It is a full-time way of life that requires long-term dedication.
MoreThe internationally renowned, Wolf Prize–winning neurobiologist’s gene therapy developments offer new hope in treatment for people with visual impairments or blindness. As the first Fellow of Frontiers, he will build a knowledge center in Hungary.
MoreHungary’s key resource is knowledge built on talent that knows no borders. Preserving and developing it is the cornerstone of future competitiveness, which is why the Frontiers Campus is being built—said Ferenc Krausz, initiator of the Frontiers Foundation, at the foundation cornerstone–laying ceremony of the building complex on March 31 in Budapest.
MoreOn February 20, the Government of Hungary and the Frontiers Foundation signed a 25-year strategic framework agreement and a 6-year financing contract, establishing a predictable, long-term foundation for the development of Hungary’s research and innovation ecosystem.
MoreSample storage has reached a new level at the CMF Biobank, Szeged: the first Askion automated cryogenic units have arrived, ensuring the long-term molecular integrity of blood plasma samples at -150°C. The first system tests have been successfully completed.
MoreOur research center's H4H Program was among the first to receive the designation of a nationally strategic medical research project.
More






